Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

Concise review: Mesenchymal stem cells for acute lung injury: role of paracrine soluble factors.

Lee JW, Fang X, Krasnodembskaya A, Howard JP, Matthay MA.

Stem Cells. 2011 Jun;29(6):913-9. doi: 10.1002/stem.643. Review.

2.

Paracrine factors from mesenchymal stem cells: a proposed therapeutic tool for acute lung injury and acute respiratory distress syndrome.

Li J, Huang S, Wu Y, Gu C, Gao D, Feng C, Wu X, Fu X.

Int Wound J. 2014 Apr;11(2):114-21. doi: 10.1111/iwj.12202. Epub 2013 Dec 26. Review.

PMID:
24373614
3.

Therapeutic implications of mesenchymal stem cells in acute lung injury/acute respiratory distress syndrome.

Wang YY, Li XZ, Wang LB.

Stem Cell Res Ther. 2013 May 2;4(3):45. doi: 10.1186/scrt193. Review.

4.

Potential application of mesenchymal stem cells in acute lung injury.

Lee JW, Gupta N, Serikov V, Matthay MA.

Expert Opin Biol Ther. 2009 Oct;9(10):1259-70. doi: 10.1517/14712590903213651. Review.

5.

Mesenchymal stem cells and acute lung injury.

Gotts JE, Matthay MA.

Crit Care Clin. 2011 Jul;27(3):719-33. doi: 10.1016/j.ccc.2011.04.004. Epub 2011 May 23. Review.

6.

Stem cell conditioned medium improves acute lung injury in mice: in vivo evidence for stem cell paracrine action.

Ionescu L, Byrne RN, van Haaften T, Vadivel A, Alphonse RS, Rey-Parra GJ, Weissmann G, Hall A, Eaton F, Thébaud B.

Am J Physiol Lung Cell Mol Physiol. 2012 Dec 1;303(11):L967-77. doi: 10.1152/ajplung.00144.2011. Epub 2012 Sep 28.

7.

Stem cell therapy for acute respiratory distress syndrome: a promising future?

Horie S, Masterson C, Devaney J, Laffey JG.

Curr Opin Crit Care. 2016 Feb;22(1):14-20. doi: 10.1097/MCC.0000000000000276. Review.

PMID:
26645555
8.

Influenza causes prolonged disruption of the alveolar-capillary barrier in mice unresponsive to mesenchymal stem cell therapy.

Gotts JE, Abbott J, Matthay MA.

Am J Physiol Lung Cell Mol Physiol. 2014 Sep 1;307(5):L395-406. doi: 10.1152/ajplung.00110.2014. Epub 2014 Jul 18.

9.

Mesenchymal stem cells in acute lung injury: are they ready for translational medicine?

Xu F, Hu Y, Zhou J, Wang X.

J Cell Mol Med. 2013 Aug;17(8):927-35. doi: 10.1111/jcmm.12063. Epub 2013 Jul 3. Review.

10.

The Immunomodulatory and Therapeutic Effects of Mesenchymal Stromal Cells for Acute Lung Injury and Sepsis.

Ho MS, Mei SH, Stewart DJ.

J Cell Physiol. 2015 Nov;230(11):2606-17. doi: 10.1002/jcp.25028. Review.

PMID:
25913273
11.

Mesenchymal stromal cell therapies: potential and pitfalls for ARDS.

Masterson C, Jerkic M, Curley GF, Laffey JG.

Minerva Anestesiol. 2015 Feb;81(2):179-94. Epub 2014 Feb 4. Review.

12.

Cell-based therapies for the acute respiratory distress syndrome.

Maron-Gutierrez T, Laffey JG, Pelosi P, Rocco PR.

Curr Opin Crit Care. 2014 Feb;20(1):122-31. doi: 10.1097/MCC.0000000000000061. Review.

PMID:
24300620
13.

Therapeutic Effects of Bone Marrow-Derived Mesenchymal Stem Cells in Models of Pulmonary and Extrapulmonary Acute Lung Injury.

Liu L, He H, Liu A, Xu J, Han J, Chen Q, Hu S, Xu X, Huang Y, Guo F, Yang Y, Qiu H.

Cell Transplant. 2015;24(12):2629-42. doi: 10.3727/096368915X687499. Epub 2015 Feb 18.

PMID:
25695285
14.

Intravenous transplantation of mesenchymal stem cells attenuates oleic acid induced acute lung injury in rats.

Xu YL, Liu YL, Wang Q, Li G, Lü XD, Kong B.

Chin Med J (Engl). 2012 Jun;125(11):2012-8.

PMID:
22884070
15.

The hepatocyte growth factor-expressing character is required for mesenchymal stem cells to protect the lung injured by lipopolysaccharide in vivo.

Hu S, Li J, Xu X, Liu A, He H, Xu J, Chen Q, Liu S, Liu L, Qiu H, Yang Y.

Stem Cell Res Ther. 2016 Apr 29;7(1):66. doi: 10.1186/s13287-016-0320-5.

16.

Transplantation of Menstrual Blood-Derived Mesenchymal Stem Cells Promotes the Repair of LPS-Induced Acute Lung Injury.

Xiang B, Chen L, Wang X, Zhao Y, Wang Y, Xiang C.

Int J Mol Sci. 2017 Mar 27;18(4). pii: E689. doi: 10.3390/ijms18040689.

17.

A therapeutic role for mesenchymal stem cells in acute lung injury independent of hypoxia-induced mitogenic factor.

Song L, Xu J, Qu J, Sai Y, Chen C, Yu L, Li D, Guo X.

J Cell Mol Med. 2012 Feb;16(2):376-85. doi: 10.1111/j.1582-4934.2011.01326.x.

18.

Mesenchymal stem cells: mechanisms of potential therapeutic benefit in ARDS and sepsis.

Walter J, Ware LB, Matthay MA.

Lancet Respir Med. 2014 Dec;2(12):1016-26. doi: 10.1016/S2213-2600(14)70217-6. Epub 2014 Oct 28. Review.

19.

Mesenchymal Stem Cells Overexpressing Angiotensin-Converting Enzyme 2 Rescue Lipopolysaccharide-Induced Lung Injury.

He H, Liu L, Chen Q, Liu A, Cai S, Yang Y, Lu X, Qiu H.

Cell Transplant. 2015;24(9):1699-715. doi: 10.3727/096368914X685087. Epub 2014 Oct 6.

PMID:
25291359
20.

Mesenchymal-stem-cell-based experimental and clinical trials: current status and open questions.

Wang J, Liao L, Tan J.

Expert Opin Biol Ther. 2011 Jul;11(7):893-909. doi: 10.1517/14712598.2011.574119. Epub 2011 Mar 30. Review.

PMID:
21449634

Supplemental Content

Support Center